NorthWest Biotherapeutics Inc (NWBO)

[EMHLondonUK]

ATL or the other long-tenured investors on this board.... has management ever included this language in its Qs/Ks before?

Although the FDA lifted its hold in February 2017 as previously reported by the Company, the Company had already closed enrollment with 331 of the planned 348 patients. Since we did not enroll the last 17 of the planned 348 patients, this could adversely affect the statistical and other analyses of our Phase III trial results, and could make it more difficult to seek product approval or more likely that further trials could be required.

Page 16

https://www.sec.gov/ix?doc=/Archives/edgar/data/1072379/000110465921044832/nwbo-20201231x10k.htm